See more : QHY Group (QHYG) Income Statement Analysis – Financial Results
Complete financial analysis of Zenlabs Ethica Limited (ZENLABS.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zenlabs Ethica Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Arihant Superstructures Limited (ASL.BO) Income Statement Analysis – Financial Results
- Freeman Gold Corp. (FMAN.V) Income Statement Analysis – Financial Results
- Carney Technology Acquisition Corp. II (CTAQ) Income Statement Analysis – Financial Results
- algoWatt S.p.A. (ALW.MI) Income Statement Analysis – Financial Results
- Voneseals Technology (Shanghai) Inc. (301161.SZ) Income Statement Analysis – Financial Results
Zenlabs Ethica Limited (ZENLABS.BO)
About Zenlabs Ethica Limited
Zenlabs Ethica Ltd. engages in trading of pharmaceutical products. Its products include: Analgesics and Anti-Inflammatory; Skin Preparations; Neurological Disorders; Ear, Eye, and Nasal Drops; Anti-Diabetic; Anti-Depressant; Antiviral; Anti-Emetic; Steroids and Anabolic Steroids; Anti-Hypertensive Drugs; Anti Allergic, Anti Cold, and Cough Syrup; Nutraceuticals; Antacid, Enzymes, and Appetite Stimulant; Ayurvedic Preparation; GIT Disorders; and Other Pharmaceutical Drugs. The company was founded on July 20, 1993 and is headquartered in Chandigarh, India.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 585.63M | 668.86M | 690.88M | 566.40M | 599.49M | 672.95M | 718.38M | 811.59M | 157.52M | 0.00 | 10.43K | 35.88M | 148.05M | 193.05M | 5.30M | 7.57M |
| Cost of Revenue | 437.88M | 533.05M | 563.94M | 467.28M | 494.59M | 520.08M | 571.14M | 654.19M | 119.81M | 0.00 | 0.00 | 41.25M | 125.58M | 158.89M | 86.00K | 2.34M |
| Gross Profit | 147.75M | 135.82M | 126.94M | 99.13M | 104.90M | 152.87M | 147.24M | 157.40M | 37.71M | 0.00 | 10.43K | -5.36M | 22.48M | 34.15M | 5.21M | 5.23M |
| Gross Profit Ratio | 25.23% | 20.31% | 18.37% | 17.50% | 17.50% | 22.72% | 20.50% | 19.39% | 23.94% | 0.00% | 100.00% | -14.95% | 15.18% | 17.69% | 98.38% | 69.13% |
| Research & Development | 0.00 | 0.00 | 0.00 | 339.57K | 54.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 44.58M | 2.35M | 2.90M | 2.79M | 3.16M | 2.38M | 3.02M | 2.45M | 57.25K | 0.00 | 368.05K | 1.63M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 13.32M | 28.62M | 29.54M | 23.75M | 22.74M | 34.94M | 33.38M | 50.66M | 7.13M | 0.00 | 69.95K | 2.22M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 57.90M | 30.97M | 32.44M | 26.54M | 25.90M | 37.31M | 36.40M | 53.11M | 7.19M | 73.44K | 437.99K | 3.86M | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 1.28M | 873.00K | 129.00K | 0.00 | 115.56M | 110.84M | 92.01M | 29.62M | 0.00 | 0.00 | 1.46M | 29.49M | 25.63M | 5.62M | 5.36M |
| Operating Expenses | 57.90M | 119.27M | 111.89M | 88.76M | 114.89M | 152.87M | 147.24M | 145.12M | 36.81M | 73.44K | 437.99K | 5.32M | 29.49M | 25.63M | 5.62M | 5.36M |
| Cost & Expenses | 496.35M | 652.32M | 675.83M | 556.04M | 609.48M | 672.95M | 718.38M | 799.31M | 156.62M | 73.44K | 437.99K | 46.57M | 155.06M | 184.53M | 5.71M | 7.70M |
| Interest Income | 248.00K | 831.00K | 849.00K | 957.00K | 586.00K | 866.01K | 850.09K | 752.76K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 8.00M | 5.33M | 3.65M | 2.85M | 2.28M | 691.91K | 877.84K | 1.00M | 228.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 12.94M | 12.51M | 8.91M | 7.14M | 2.92M | 2.25M | 2.03M | 2.04M | 578.12K | 92.30K | 136.71K | 223.58K | 100.00K | 70.00K | 29.00K | 26.36K |
| EBITDA | 26.76M | 24.59M | 24.77M | 18.59M | -6.47M | 20.92M | 19.44M | 14.58M | 1.71M | -509.91K | -427.55K | -10.44M | -6.91M | 8.59M | -383.00K | -105.14K |
| EBITDA Ratio | 4.57% | 4.54% | 3.59% | 3.30% | -1.14% | 3.11% | 2.71% | 1.80% | 1.08% | 0.00% | -4,099.62% | -29.09% | -4.67% | 4.45% | -7.23% | -1.39% |
| Operating Income | 89.28M | 17.83M | 15.86M | 11.58M | -9.73M | 18.63M | 18.55M | 12.28M | 900.98K | -73.44K | -427.56K | -10.68M | -7.01M | 8.52M | -412.00K | -131.50K |
| Operating Income Ratio | 15.24% | 2.67% | 2.30% | 2.04% | -1.62% | 2.77% | 2.58% | 1.51% | 0.57% | 0.00% | -4,099.76% | -29.77% | -4.73% | 4.41% | -7.78% | -1.74% |
| Total Other Income/Expenses | -83.46M | -75.92M | -67.20M | -48.21M | -1.93M | 274.72K | -2.01M | 0.00 | 0.00 | -528.77K | -136.70K | -0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | 5.82M | 6.75M | 12.21M | 8.60M | -11.68M | 18.90M | 16.54M | 12.28M | 900.98K | -602.21K | -564.26K | -10.68M | -7.01M | 8.52M | -412.00K | -131.50K |
| Income Before Tax Ratio | 0.99% | 1.01% | 1.77% | 1.52% | -1.95% | 2.81% | 2.30% | 1.51% | 0.57% | 0.00% | -5,410.48% | -29.77% | -4.73% | 4.41% | -7.78% | -1.74% |
| Income Tax Expense | 1.60M | 1.85M | 4.39M | 926.00K | 4.35M | 6.27M | 4.90M | 2.76M | -801.41K | 61.76K | 0.00 | 0.00 | 0.00 | 2.63M | 0.00 | 800.00 |
| Net Income | 4.21M | 4.89M | 7.82M | 7.67M | -7.33M | 12.63M | 11.64M | 9.52M | 1.70M | -663.98K | -564.26K | -10.68M | -7.01M | 5.89M | -412.00K | -132.30K |
| Net Income Ratio | 0.72% | 0.73% | 1.13% | 1.35% | -1.22% | 1.88% | 1.62% | 1.17% | 1.08% | 0.00% | -5,410.48% | -29.77% | -4.73% | 3.05% | -7.78% | -1.75% |
| EPS | 0.65 | 0.75 | 1.20 | 1.18 | -1.13 | 1.94 | 1.79 | 1.46 | 0.26 | -0.17 | -0.15 | -2.81 | -1.84 | 1.55 | 0.00 | 0.00 |
| EPS Diluted | 0.65 | 0.75 | 1.20 | 1.18 | -1.13 | 1.94 | 1.79 | 1.46 | 0.26 | -0.17 | -0.15 | -2.81 | -1.84 | 1.55 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 6.48M | 6.52M | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M | 3.80M | 3.80M | 3.80M | 3.81M | 3.80M | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 6.48M | 6.52M | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M | 6.51M | 3.80M | 3.80M | 3.80M | 3.81M | 3.80M | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports